Elena Pacella
Overview
Explore the profile of Elena Pacella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magna A, Polisena N, Polisena L, Bagnato C, Pacella E, Carnevale R, et al.
Antioxidants (Basel)
. 2024 Nov;
13(11).
PMID: 39594537
Electronic cigarettes and heated tobacco products have seen significant growth in sales and usage in recent years. Initially promoted as potentially less harmful alternatives to traditional tobacco, recent scientific evidence...
2.
Malvasi M, Calandri A, Pacella E, Vingolo E
Cutan Ocul Toxicol
. 2024 Nov;
43(4):369-382.
PMID: 39560148
Purpose: Intravitreal drug administration has become the gold standard for the treatment of many retinal diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR) and retinal vein occlusion (RVO). The...
3.
Malvasi M, Compagno S, Segnalini A, Malvasi V, Pacella F, Turchetti P, et al.
Clin Optom (Auckl)
. 2024 May;
16:131-142.
PMID: 38798785
Background: The success of fixation training using microperimetric biofeedback (MP-3 MBFT) in the realm of visual rehabilitation for patients with central vision loss caused by macular pathologies is well established....
4.
Forte G, Battagliola E, Malvasi M, Ruberti N, Daniele P, Mantovani A, et al.
Biol Trace Elem Res
. 2024 Apr;
203(2):684-693.
PMID: 38687421
Cataract, characterized by the opacification of the lens, is the leading cause of reversible blindness and visual impairment globally. The study aims to investigate the role of trace elements such...
5.
Comberiati A, Lomartire C, Malvasi M, Migliorini R, Pacella F, Malvasi V, et al.
Clin Optom (Auckl)
. 2024 Feb;
16:55-69.
PMID: 38410094
Purpose: To evaluate ocular motility (OM) disorders and strabismus in a sample of patients with retinitis pigmentosa (RP) and a control sample. Methods: In this cross-sectional retrospective analysis, we studied...
6.
Capone L, Airaghi P, Aragona P, Castellino N, Cicinelli M, Ciucci F, et al.
Eur J Ophthalmol
. 2024 Feb;
34(6):1837-1842.
PMID: 38396370
Objectives: to evaluate long-term effectiveness and safety of fluocinolone acetonide (FAc) implant used as second-line treatment in patients with persistent diabetic macular edema (DME). Methods: retrospective data chart review of...
7.
Battagliola E, Riveros Cabral R, Manco G, Puggioni G, Brancato C, Mangiantini P, et al.
Graefes Arch Clin Exp Ophthalmol
. 2023 May;
261(10):2953-2959.
PMID: 37199800
Purpose: To explore whether topical antibiotic prophylaxis in patients scheduled for intravitreal injections achieves surface sterility in a greater proportion of subjects as compared to povidone-iodine alone. Material And Methods:...
8.
Lo Faro A, Tini A, Bambagiotti G, Pirani F, Faragalli A, Carle F, et al.
Biology (Basel)
. 2022 Oct;
11(10).
PMID: 36290285
Carbonic anhydrase inhibitors (CAIs) are prescription drugs also used in doping to dilute urine samples and tamper with urinalyses. Dorzolamide, brinzolamide, and acetazolamide are prohibited by the World Anti-Doping Agency....
9.
Ragno R, Minarini A, Proia E, Lorenzo A, Milelli A, Tumiatti V, et al.
J Chem Inf Model
. 2022 Aug;
62(16):3910-3927.
PMID: 35948439
Natural polyamines (PAs) are key players in cellular homeostasis by regulating cell growth and proliferation. Several observations highlight that PAs are also implicated in pathways regulating cell death. Indeed, the...
10.
Battagliola E, Mangiantini P, DAndrea M, Malvasi M, Loffredo L, Scalinci S, et al.
Eur J Ophthalmol
. 2022 Jun;
33(1):112-122.
PMID: 35678641
Purpose: to explore the potential consequences of the COVID-19 lockdown on the prevalence of myopia among Italian children aged 5-12 years. Materials And Methods: retrospective multicenter study conducted in Italy....